Natera, Inc. Common Stock (NTRA) Stock Price

NTRAStock

$336.71+97.90%52W

Market Cap$48.53B

P/E—

PEG Ratio—

Div yield—

Beta1.56

NTRA Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)40.81%

Price vs S&P 500 (4W)26.88%

VGM Score61.07

P/CF (Annual)207.34x

Book Value / Share (Quarterly)$12.68

P/TBV (Annual)23.67x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)41.14%

Cash Flow / Share (Quarterly)$0.36

Price vs S&P 500 (YTD)31.09%

Gross Margin (TTM)65.23%

Net Profit Margin (TTM)-7.11%

EPS (TTM)$-1.37

10-Day Avg Trading Volume1.37M

EPS Excl Extra (TTM)$-1.37

Revenue Growth (5Y)42.61%

EPS (Annual)$-1.52

ROI (Annual)-11.61%

Gross Margin (Annual)64.75%

Net Profit Margin (5Y Avg)-40.52%

Cash / Share (Quarterly)$7.60

Revenue Growth QoQ (YoY)37.71%

ROA (Last FY)-8.68%

Revenue Growth TTM (YoY)37.82%

EBITD / Share (TTM)$-1.90

ROE (5Y Avg)-46.95%

Operating Margin (TTM)-10.70%

Cash Flow / Share (Annual)$0.54

P/B Ratio24.51x

P/B Ratio (Quarterly)21.34x

Net Income / Employee (Annual)$-33,900

EV / Revenue (TTM)16.12x

Net Interest Coverage (TTM)-57.80x

ROA (TTM)-8.11%

EPS Incl Extra (Annual)$-1.52

Current Ratio (Annual)3.39x

Quick Ratio (Quarterly)2.74x

3-Month Avg Trading Volume1.48M

52-Week Price Return97.90%

EV / Free Cash Flow (Annual)573.23x

Revenue / Employee (TTM)$441,300

Tangible BV / Share (Quarterly)$10.18

P/S Ratio (Annual)19.36x

Asset Turnover (Annual)0.96x

52-Week High$333.56

Operating Margin (5Y Avg)-41.71%

EPS Excl Extra (Annual)$-1.52

CapEx CAGR (5Y)48.00%

Tangible BV CAGR (5Y)94.40%

26-Week Price Return52.05%

Quick Ratio (Annual)3.11x

13-Week Price Return60.89%

Total Debt / Equity (Annual)0.05x

Current Ratio (Quarterly)3.00x

Enterprise Value$43.63B

Revenue / Share Growth (5Y)28.43%

Asset Turnover (TTM)1.14x

Book Value / Share Growth (5Y)16.79%

Revenue / Employee (Annual)$375,900

Inventory Turnover (Annual)14.36x

Pretax Margin (Annual)-11.63%

Cash / Share (Annual)$7.70

3-Month Return Std Dev58.78%

Gross Margin (5Y Avg)52.81%

Net Income / Employee (TTM)$-31,400

ROE (Last FY)-12.16%

Net Interest Coverage (Annual)-39.23x

EPS Basic Excl Extra (Annual)$-1.52

P/FCF (TTM)624.27x

Receivables Turnover (TTM)7.40x

EV / Free Cash Flow (TTM)852.20x

Total Debt / Equity (Quarterly)0.04x

EPS Incl Extra (TTM)$-1.37

Receivables Turnover (Annual)7.55x

ROI (TTM)-11.18%

P/S Ratio (TTM)16.49x

Pretax Margin (5Y Avg)-40.99%

Revenue / Share (Annual)$16.87

Tangible BV / Share (Annual)$9.58

Price vs S&P 500 (52W)79.59%

Year-to-Date Return43.05%

5-Day Price Return5.14%

EPS Normalized (Annual)$-1.52

ROA (5Y Avg)-25.55%

Net Profit Margin (Annual)-9.03%

Month-to-Date Return22.39%

Cash Flow / Share (TTM)$-4.30

EBITD / Share (Annual)$-2.25

Operating Margin (Annual)-13.44%

LT Debt / Equity (Annual)0.00x

P/CF (TTM)195.59x

ROI (5Y Avg)-32.86%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-1.37

P/TBV (Quarterly)26.60x

P/B Ratio (Annual)18.50x

Inventory Turnover (TTM)13.98x

Pretax Margin (TTM)-9.33%

Book Value / Share (Annual)$12.26

Price vs S&P 500 (13W)58.10%

Beta1.56x

P/FCF (Annual)586.52x

Revenue / Share (TTM)$18.89

ROE (TTM)-11.73%

52-Week Low$157.43

vGradeF

gGradeA

mGradeA

vgmGradeB

NTRA Earnings Surprise History

Q2 25-0.74est. -0.59

Q3 25-0.64est. -0.35

Q4 250.36est. -0.53

Q1 26-0.60est. -0.55

Q2 26-0.47est. -0.53

NTRA Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.29

4.30

4.27

Industry Peers — Health Services(30)

Symbol	Value Score	Growth Score	Momentum Score	Price
NTRANatera, Inc. Common Stock	F	A	A	$336.71
LHLabcorp Holdings Inc.	C	D	B	$337.68
DGXQuest Diagnostics Inc.	C	D	B	$244.51
GHGuardant Health, Inc. Common Stock	F	A	A	$164.92
CAICaris Life Sciences, Inc. Common Stock	F	A	B	$28.01
RDNTRadNet, Inc. Common Stock	D	C	C	$76.86
BLLNBillionToOne, Inc. Class A Common Stock	F	F	C	$100.08
CELCCelcuity Inc. Common Stock	—	—	D	$92.27
GRALGRAIL, Inc. Common Stock	D	A	B	$82.54
VCYTVeracyte, Inc.	D	A	C	$44.04
CDNACareDx, Inc.	D	B	A	$50.80
PSNLPersonalis, Inc. Common Stock	F	D	A	$17.25
FTREFortrea Holdings Inc. Common Stock	B	F	A	$18.27
FRNMFreenome, Inc. Common stock	—	F	A	$13.99
LMRILumexa Imaging Holdings, Inc. Common Stock	C	C	B	$12.07
CSTLCastle Biosciences, Inc. Common Stock	D	B	B	$35.00
FLGTFulgent Genetics, Inc. Common Stock	C	D	C	$19.95
YDESYD Bio Limited Ordinary Shares	—	—	D	$4.68
BDSXBiodesix, Inc. Common Stock	D	B	A	$28.07
XGNExagen Inc. Common Stock	D	B	B	$7.60
PCSCPerceptive Capital Solutions Corp Class A Ordinary Shares	—	F	B	$11.95
BNRBurning Rock Biotech Limited American Depositary Shares	B	F	D	$9.80
SERASera Prognostics, Inc. Class A Common Stock	D	D	C	$2.18
MDXHMDxHealth SA Ordinary Shares	B	B	F	$0.79
ADVBAdvanced Biomed Inc. Common Stock	A	—	B	$9.18
AMSAmerican Shared Hospital Services	A	C	D	$1.47
ACONAclarion, Inc. Common Stock	—	B	D	$2.49
BGLCBioNexus Gene Lab Corp Common stock	B	F	F	$1.55
ACONWAclarion, Inc. Warrant	—	—	D	$0.03
EXASExact Sciences Corp	F	B	B	$0.00
YDESWYD Bio Limited Warrants	—	—	D	$0.36

About Natera, Inc. Common Stock

Natera provides molecular diagnostic tests across reproductive health, oncology, and transplantation. Its main products include Panorama for non-invasive prenatal screening, Horizon for genetic carrier assessment, Signatera for circulating tumor DNA detection in cancer monitoring, and Prospera for organ transplant rejection assessment. The company leverages proprietary molecular and bioinformatics technology across these applications.